These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 17292492)
1. N-terminal pro-atrial natriuretic peptide and exercise prescription in patients with myocardial infarction. Ikeda N; Yasu T; Nishikimi T; Nakamura T; Kubo N; Kawakami M; Momomura S; Saito M Regul Pept; 2007 Jun; 141(1-3):154-8. PubMed ID: 17292492 [TBL] [Abstract][Full Text] [Related]
2. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance. Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423 [TBL] [Abstract][Full Text] [Related]
3. Favourable effects of exercise training on N-terminal pro-brain natriuretic peptide plasma levels in elderly patients after acute myocardial infarction. Giallauria F; Lucci R; De Lorenzo A; D'Agostino M; Del Forno D; Vigorito C Age Ageing; 2006 Nov; 35(6):601-7. PubMed ID: 16951263 [TBL] [Abstract][Full Text] [Related]
5. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction. Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235 [TBL] [Abstract][Full Text] [Related]
6. [Changes in plasma level of brain natriuretic peptide during exercise in recovery phase of myocardial infarction and the clinical significance]. Yokoyama Y; Tanabe K; Yamada S; Itoh H J Cardiol; 1996 Mar; 27(3):121-31. PubMed ID: 8865684 [TBL] [Abstract][Full Text] [Related]
7. Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide. Giallauria F; Cirillo P; Lucci R; Pacileo M; De Lorenzo A; D'Agostino M; Moschella S; Psaroudaki M; Del Forno D; Orio F; Vitale DF; Chiariello M; Vigorito C Eur J Cardiovasc Prev Rehabil; 2008 Feb; 15(1):113-8. PubMed ID: 18277196 [TBL] [Abstract][Full Text] [Related]
8. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients. Hoffmann U; Brueckmann M; Bertsch T; Wiessner M; Liebetrau C; Lang S; Haase KK; Borggrefe M; Huhle G Clin Lab; 2005; 51(7-8):373-9. PubMed ID: 16122147 [TBL] [Abstract][Full Text] [Related]
9. Natriuretic peptides in patients with aortic stenosis. Qi W; Mathisen P; Kjekshus J; Simonsen S; Bjørnerheim R; Endresen K; Hall C Am Heart J; 2001 Oct; 142(4):725-32. PubMed ID: 11579366 [TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of plasma atrial and brain natriuretic peptide levels during hemodialysis in hemodialysis patients with old myocardial infarction]. Uetake S; Takahashi M; Tamano K; Honda T; Kobayashi T; Horinaka S J Cardiol; 2001 Aug; 38(2):61-71. PubMed ID: 11525111 [TBL] [Abstract][Full Text] [Related]
11. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide. Jarai R; Iordanova N; Jarai R; Raffetseder A; Woloszczuk W; Gyöngyösi M; Geyer G; Wojta J; Huber K Eur Heart J; 2005 Feb; 26(3):250-6. PubMed ID: 15618049 [TBL] [Abstract][Full Text] [Related]
16. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction. Steen H; Futterer S; Merten C; Jünger C; Katus HA; Giannitsis E J Cardiovasc Magn Reson; 2007; 9(5):749-58. PubMed ID: 17891611 [TBL] [Abstract][Full Text] [Related]
17. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels. Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726 [TBL] [Abstract][Full Text] [Related]
18. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease. Elmas E; Brueckmann M; Lang S; Kälsch T; Haghi D; Sueselbeck T; Dempfle CE; Borggrefe M Int J Cardiol; 2008 Aug; 128(2):244-9. PubMed ID: 17673312 [TBL] [Abstract][Full Text] [Related]
19. [The examination of clinical prognostic importance of atrial and brain natriuretic peptide in patients with acute myocardial infarction]. Mazurek W; Salomon P Pol Merkur Lekarski; 2002 Jan; 12(67):15-9. PubMed ID: 11957795 [TBL] [Abstract][Full Text] [Related]
20. Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy. Staudt A; Staudt Y; Hummel A; Empen K; Dörr M; Trimpert C; Birkenmeier K; Kühl U; Noutsias M; Russ D; Felix SB Ther Apher Dial; 2006 Feb; 10(1):42-8. PubMed ID: 16556135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]